Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Bright Biologics logo — Developing bispecific antibody drug to improve cancer treatm...

Bright Biologics

Developing bispecific antibody drug to improve cancer treatment.

Founded 2020 United States Sunnyvale, United States 6 employees Biotechnology, Health Care +1

General Information

Company Name Bright Biologics
Founded Year 2020
Location United States Sunnyvale, United States
Employees 6
Industries Biotechnology, Health Care, Health and Wellness
Social

BounceWatch is an independent company data service, not affiliated with Bright Biologics. To contact Bright Biologics, visit brightbiologicsllc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bright Biologics compare?

A PDF of Bright Biologics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bright Biologics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bright Biologics

Bright Biologics is a United States-based startup that focuses on developing bispecific antibody drugs to improve cancer treatment. They aim to target clinically proven targets and utilize a highly efficient VHH antibody discovery platform and state-of-the-art screening technology for drug development.

Founded in 2020, the company operates in the biotechnology and health care industries, positioning itself at the intersection of cutting-edge medical research and technology.

Although information about their last investment and investors is currently unavailable, Bright Biologics' emphasis on improving cancer treatment through innovative antibody drugs presents an exciting investment opportunity for venture capitalists seeking to support potentially groundbreaking advancements in the field of oncology.

Business keywords: Bispecific antibody drug, Therapeutic antibodies, Cancer treatment, VHH antibody discovery, Antibody drug development, Molecular biology, Protein chemistry, ADC, Cancer research

No funding data available for Bright Biologics yet.

Bright Biologics Alternatives & Competitors

View All Alternatives
Bright Biologics vs
Merus N.V.
Merus N.V. The Netherlands

Merus was acquired by Genmab. To see what’s new, visit Genmab.

Post-IPO Equity
177 employees
Biotechnology, Health Care
Bright Biologics vs
Iksuda Therapeutics
Iksuda Therapeutics United Kingdom

Creating class-leading ADCs with enhanced tumor specificity

Series A
43 employees
Biopharma, Biotechnology
Bright Biologics vs
Wuhan YZY Biopharma Co. Ltd.
Wuhan YZY Biopharma Co. Ltd. China

Wuhan YZY Biopharma Co. Ltd. YZY Biopharma is a biotech company whose vision is to develop new cl...

Series C
55 employees
Biotechnology, Health Care
View all alternatives

FAQ About Bright Biologics

Developing bispecific antibody drug to improve cancer treatment.
Bright Biologics was founded in 2020.
Bright Biologics is headquartered in Sunnyvale, United States.
Bright Biologics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Bispecific antibody drug, Therapeutic antibodies, Cancer treatment and VHH antibody discovery.
Bright Biologics has approximately 6 employees.
Top alternatives and competitors to Bright Biologics include Merus N.V., Iksuda Therapeutics, Wuhan YZY Biopharma Co. Ltd., Biotheus Inc., ADC Biotechnology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bright Biologics and Merus N.V. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bright Biologics, https://bouncewatch.com/company/bright-biologics, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout